Additional Partners

Abbott Laboratories is an American multinational medical devices and health care company. The Abbott Fund has pledged US$5 million to the Integrated Laboratory Systems Strengthening Catalytic Fund in partnership with The Rockefeller Foundation.

Absa, a pan-African bank and purpose-led organization, is working with the Global Fund to leverage its voice, marketing and communication platforms to raise awareness of the importance of investing in health, as well as explore how to attract private capital to strengthen healthcare systems and supply chains across Africa. Absa has also provided financial support to a new social impact bond designed to improve HIV prevention amongst adolescent girls and young women in South Africa and has supported the South African Government’s pledge for the Seventh Replenishment. This aligns with the Group’s purpose of “empowering Africa’s tomorrow, together... one story at a time”.

Coca-Cola partners with the Global Fund through Project Last Mile, leveraging its supply chain, logistics and marketing expertise to improve access to lifesaving medicines and health services in hard-to-reach communities across Africa. By applying Coca-Cola’s proven distribution and consumer insight strategies, the initiative strengthens public health systems, enhances cold chain capabilities and ensures more reliable delivery of essential health products. This partnership exemplifies how private sector innovation can be harnessed to solve public health challenges and drive public health impact, especially in resource limited settings. Since 2010, Project Last Mile has reached over 35 million people across 12 countries in Africa with activities that included:

- Training more than 11,600 health care workers in cold chain and inventory management.
- Supporting decentralized service delivery for chronic medications, including HIV, benefiting over 3 million people.
- Reaching more than 25 million people with campaigns promoting health-seeking behaviors.

Dimagi will invest US$5 million to support countries where the Global Fund invests to build and scale electronic community health information systems, to integrate CommCare applications at the community level into wider system data flows, and to introduce new digital innovations into established CommCare platforms. This contribution will support data-driven planning and prioritization to improve community health worker jobs and strengthen community health systems at the last mile in these countries.

As a key membership-based business organization, the French Council of Investors in Africa (CIAN) partners with the Global Fund to strengthen relationships with the French private sector and accelerate its engagement in the fight against HIV, tuberculosis and malaria across sub-Saharan Africa.

The Global Fund’s partnership with GBCHealth leverages a network of over 200 companies committed to investing their resources and capabilities to strengthen supply chain management across Africa. A new platform coordinated by GBCHealth and intended to grow to include a diverse range of sectors enables the engagement of the great range and depth of corporate core competencies such as cold chain, route to market optimization, and last mile delivery – contributing to increasing medicine availability and improving supply chain efficiencies.

GSK and ViiV Healthcare have pledged GBP 2 million to support the Global Fund’s Emergency Fund for Ukraine. This contribution is intended to support the delivery of HIV and TB prevention, testing and treatment services for Ukrainian people and communities.

Help Logistics is a three-year framework for collaboration aimed at strengthening health supply chain systems and enhancing pandemic preparedness in countries supported by The Global Fund. The partnership will tap into core competencies from Kuhne & Nagel to help build local capacities in supply chain management.

Key areas of cooperation:

- Supply chain analysis: Use data analytics to assess and improve health supply chain systems, focusing on preparedness, efficiency, digitalization, sustainability and climate resilience.
- Capacity building: Develop and deliver training programs to enhance the capabilities of Global Fund Grant Implementers in procurement and supply chain management.
- Advocacy and awareness: Promote the importance of logistics in health outcomes through research, publications and both global and local engagement.

Ms. Le Nu Thuy Duong, Vice Chairwoman and CEO, KN Holdings, became Global Fund partner in 2019 to support tuberculosis programs in her native Viet Nam. Through Long Thanh Golf Investment and Trading she pledged US$1 million at the Global Fund’s Sixth Replenishment, and a further US$3 million at the Seventh Replenishment in 2022. These contributions were further bolstered by matching funds from the Bill & Melinda Gates Foundation, resulting in a US$11 million total commitment to the Global Fund. Ms. Duong’s support has helped expand the critical work of fighting pediatric tuberculosis led by the government of Viet Nam.

Medic will invest US$3 million to support countries where the Global Fund invests to scale up existing Community Health Toolkits (CHT) at a national level, to build a more robust and holistic record of patient care and to decentralize expertise to ensure the opportunity for sustainable local ownership of health system technology infrastructure. This contribution will largely help build capacity by enabling specialists to design community health systems at the last mile in these countries.

Medtronic LABS is supporting the Global Fund with US$100,000 and US$5 million in in-kind resources. These contributions will support work focused on digital health innovation and digital infrastructure in Africa. First, the partnership will expand the disease applications of the SPICE platform to include more than ten disease pathways, including HIV, TB, malaria and others, aligning with country priorities. Second, the partnership will open source the SPICE platform to become a digital public good or global good. Third, the partnership will deepen core technology capabilities, including expanding ML/AI machinery for a predictive approach to population health. Fourth, the partnership will focus on training and capacity building for health care workers in digital literacy and data for health, as well as clinical guidelines in health areas. Finally, the partnership will expand Medtronic LABS geographic footprint via public private partnerships.

Microsoft partners with the Global Fund to strengthen digital health infrastructure and improve data integration across health systems in low- and middle-income countries. Their collaboration focuses on enhancing interoperability between national health information systems and supporting the development of data governance frameworks. A key initiative includes the co-development of a Framework for Data Management and Interoperability Standards with the Government of Rwanda and Mastercard, which now serves as a strategic pillar of Rwanda’s national digital health strategy. This methodology is being explored for adaptation in other Global Fund-supported countries.

Microsoft has also provided Microsoft Teams licenses to civil society organizations in 53 countries, enabling virtual collaboration during the COVID-19 pandemic.

The Novartis Foundation is working with the Global Fund to accelerate and scale data and healthtech solutions to deliver real-time insights for improved decision making and more equitable access to health services in Africa. This will include building institutional and entrepreneurial capacity around data and digital health through the HealthTech Hub Africa, scaling local healthtech solutions and helping to shape innovative and sustainable models for healthtech financing.

Tapping into the immense potential of mobile phone technology, Orange and the Global Fund have partnered since 2019 to leverage Orange’s expertise and technology to develop digital platforms that improve access to health services and build stronger health data systems in Africa. Orange renewed its partnership with an additional US$5 million in-kind pledge supporting the Digital Health Impact Accelerator for the Seventh Replenishment, covering 2023-2025. This pledge builds on the previous in-kind contribution valued at US$2.5 million over 2020-2022 to support Morocco and Côte d'Ivoire.

The Global Fund’s partnership with PharmAccess Foundation supports African countries to accelerate progress toward universal health coverage by harnessing digital technology. PharmAccess, a Dutch nongovernmental organization with a presence in Africa, is dedicated to championing the development of mobile and digital technology platforms to expand access to affordable health care in sub-Saharan Africa.

The Global Fund and Roche formed a partnership in 2022 to strengthen diagnostic capacity and pandemic preparedness in low- and middle-income countries, with a focus on HIV and tuberculosis (TB). Through Roche’s Global Access Program, the collaboration aims to improve access to essential diagnostic tools, enhance laboratory infrastructure and address systemic challenges such as health care waste management, sample transport and workforce training.

Key initiatives include:

- Supporting the integration of HIV and TB lab networks in countries like Nigeria.
- Assisting Eswatini in building a centralized facility for health care waste management.
- Promoting the recycling of lab equipment and building local capacity through the African Diagnostics and Medical Instrument Recycling (ADMIRe) Coalition.
- Piloting new technologies in 2 countries, with plans to scale to 10 countries over five years.

In 2025, Roche renewed its commitment to the Global Fund in support of the Eighth Replenishment (covering 2026-2028) with an in-kind contribution of US$1 million in technical assistance. This support will help drive improvements across the diagnostic ecosystem – from integration and digital tools to sample transport, governance, and business planning.

This partnership is pivotal in expanding equitable access to diagnostics, improving health outcomes and building resilient health systems capable of responding to future pandemics.

The Global Fund and Siemens Healthineers formed a strategic partnership in 2023 to accelerate the use of artificial intelligence (AI) in the diagnosis of tuberculosis (TB), a disease that remains one of the world’s deadliest infectious killers. The collaboration aims to enhance early detection by integrating AI into chest X-ray screening, enabling faster and more accurate diagnosis – especially in underserved and remote areas. The initiative initially focuses on the Philippines, a country with one of the highest TB burdens globally. Siemens Healthineers, in collaboration with Qure.AI, is providing free AI software licenses and training health care workers to incorporate AI into their diagnostic workflows. 126,000 people per month across 28 sites will be tested. This approach not only increases the number of people who can be screened but also helps identify “missing” TB cases that would otherwise go undetected. By leveraging AI, the partnership seeks to overcome persistent challenges in TB diagnosis and contribute to the Global Fund’s broader mission of ending AIDS, TB and malaria as public health threats.

SC Johnson has collaborated with the Global Fund since 2022 through an in-kind partnership that leverages its expertise in entomology and consumer science to strengthen malaria prevention efforts. As a global leader in household pest control, SC Johnson supports national malaria control programs by enhancing entomological capacity, addressing insecticide resistance and improving laboratory management. The partnership also focuses on uncovering consumer insights to help design more effective, beneficiary-centered malaria interventions and communication strategies.

ViiV Healthcare, through its Positive Action programs and partnership with the Global Fund, continues to empower adolescent girls, young women and their communities to take the lead in shaping and driving community-led responses to the HIV epidemic. As part of its three-year strategic partnership with the Global Fund, ViiV supports the next phase of HER Voice. Specifically, it focuses on financing and capacity building among adolescent girls’ and young women’s groups to improve programmatic effectiveness, strengthen participation in Global Fund country processes and build the capacity of organizations and networks of young women. Learn more

Zenysis Technologies supports countries to strengthen health systems through improved data integration and interoperability. Their platform is an example of delivering interoperability – it consolidates fragmented health data from multiple sources into a unified system, enabling ministries of health to access timely, comprehensive information for decision making. 

Since 2018, Zenysis contributed over US$11 million in support of country-level digital transformation. As part of the Digital Health Impact Accelerator (DHIA), Zenysis is a key in-kind partner under the Seventh Replenishment, contributing services across DHIA countries.